Johnson & Johnson (JNJ)

Financing Cash Flow

-$25.15B

TTM · Period ending: · USD

JNJ logo

JNJ Financing Cash Flow

Latest reported-$25.15B
JNJ TTM Cash from Financing (-$263.00M → -$25.15B)
High-resolution chart · PNG

JNJ financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Johnson & Johnson Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
-25,153,000,000
-15,431,000,000
-5,539,000,000
-5,510,000,000
-6,465,000,000
6,744,000,000
-3,132,000,000
-6,447,000,000
-7,882,000,000
-21,417,000,000
-15,825,000,000
-9,470,000,000
-2,078,000,000
1,652,000,000
-8,871,000,000
-14,007,000,000
-12,289,000,000
-13,307,000,000
-14,047,000,000
-16,255,000,000
-9,852,000,000
-6,930,000,000
-6,120,000,000
-4,548,000,000
-12,637,000,000
-16,814,000,000
-18,015,000,000
-20,332,000,000
-19,916,000,000
-18,056,000,000
-18,510,000,000
-15,658,000,000
-14,250,000,000
-13,493,000,000
-7,673,000,000
-7,600,000,000
-8,976,000,000
-8,523,000,000
-8,551,000,000
-8,378,000,000
-6,758,000,000
-7,797,000,000
-10,846,000,000
-8,174,000,000
-12,065,000,000
-12,430,000,000
-12,260,000,000
-10,459,000,000
-9,262,000,000
-8,371,000,000
-6,091,000,000
-8,744,000,000
-18,730,000,000
-20,156,000,000
-20,562,000,000
-19,847,000,000
-7,574,000,000
-4,810,000,000
-4,452,000,000
-1,090,000,000
-557,000,000
-1,983,000,000
-4,980,000,000
-6,508,000,000
-8,051,000,000
-8,046,000,000
-4,092,000,000
-9,640,000,000
-8,094,000,000
-6,222,000,000
-7,464,000,000
-4,842,000,000
-4,376,000,000
-5,723,000,000
-5,698,000,000
-1,547,000,000
-3,771,000,000
-6,030,000,000
-6,109,000,000
-9,236,000,000
-7,100,000,000
-4,466,000,000
-4,521,000,000
-5,104,000,000
-4,955,000,000
-4,864,000,000
-5,148,000,000
-5,787,000,000
-6,438,000,000
-4,357,000,000
-3,863,000,000
-2,879,000,000
-2,733,000,000
-5,799,000,000
-6,953,000,000
-7,952,000,000
-7,422,000,000
-6,253,000,000
-5,251,000,000
-3,690,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.